Literature DB >> 18055062

Peripheral lung carcinoma: correlation of angiogenesis and first-pass perfusion parameters of 64-detector row CT.

Yuan Li1, Zhi-Gang Yang, Tian-Wu Chen, Hui-Jiao Chen, Jia-Yu Sun, Yan-Rong Lu.   

Abstract

PURPOSE: To investigate the value of 64-detector row CT first-pass perfusion imaging in the evaluation of tumor perfusion in patients with lung carcinoma, and to assess the correlation between the perfusion parameters and tumor angiogenesis.
MATERIALS AND METHODS: Forty-six surgically peripheral lung carcinomas were examined with 64-detector row CT. First-pass CT perfusion study comprised of 12 repeated spiral acquisitions over 60s following a 50-ml intravenous bolus of contrast medium at 6-7 ml/s. Tumor specimens were assessed for microvessel density (MVD). Perfusion, peak enhancement intensity (PEI), time to peak (TTP), and blood volume (BV) and MVD of the tumor were compared by means of one-way ANOVA analysis of variance among histological type, size, metastasis and necrosis. Pearson correlation coefficients were conducted to represent the relationships between the perfusion parameters and MVD of the tumor.
RESULTS: Mean values for perfusion, PEI, TTP, and BV of the 46 tumors were 70.3+/-39.4 ml/min/ml, 67.0+/-37.6 HU, 36.9+/-11.2s, and 34.9+/-17.9 ml/100g, respectively. No statistically significant differences in perfusion parameters were found among different histological types (p>0.05). Considerable differences with higher perfusion, PEI and BV were noted in tumor < or = 3.0 cm than in tumor>3.0 cm (p<0.05). No statistically significant differences were found between nodule metastasis positive and negative groups (p>0.05). The necrotic tumors showed significantly lower perfusion, PEI and BV compared with non-necrotic tumors (p<0.05). Perfusion, PEI, and BV of the necrotic part manifested significantly lower, but TTP longer, than those of non-necrotic part of the necrotic tumors (p<0.05). Perfusion, PEI and BV were positively correlated with extent of MVD (r=0.715, 0.681, 0.762, respectively, all p<0.001), whereas no significant correlation was found between TTP and MVD (r=-0.154, p>0.05).
CONCLUSION: 64-detector row CT first-pass perfusion imaging is a valuable noninvasive method in evaluating tumor perfusion of peripheral lung carcinoma. CT perfusion parameters can be indicators for evaluating tumor necrosis and angiogenesis.

Entities:  

Mesh:

Year:  2007        PMID: 18055062     DOI: 10.1016/j.lungcan.2007.10.021

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  37 in total

1.  Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging.

Authors:  Davide Ippolito; Cristina Capraro; Alessandra Casiraghi; Cristina Cestari; Sandro Sironi
Journal:  Eur Radiol       Date:  2011-11-16       Impact factor: 5.315

2.  64-row MDCT perfusion of head and neck squamous cell carcinoma: technical feasibility and quantitative analysis of perfusion parameters.

Authors:  Lorenzo Faggioni; Emanuele Neri; Francesca Cerri; Eugenia Picano; Veronica Seccia; Luca Muscatello; Stefano Sellari Franceschini; Carlo Bartolozzi
Journal:  Eur Radiol       Date:  2010-07-23       Impact factor: 5.315

3.  Dynamic contrast-enhanced CT in suspected lung cancer: quantitative results.

Authors:  S W Harders; H H Madsen; H M Nellemann; T R Rasmussen; J Thygesen; H Hager; N T Andersen; F Rasmussen
Journal:  Br J Radiol       Date:  2013-09-12       Impact factor: 3.039

Review 4.  Advances in Imaging and Automated Quantification of Malignant Pulmonary Diseases: A State-of-the-Art Review.

Authors:  Bruno Hochhegger; Matheus Zanon; Stephan Altmayer; Gabriel S Pacini; Fernanda Balbinot; Martina Z Francisco; Ruhana Dalla Costa; Guilherme Watte; Marcel Koenigkam Santos; Marcelo C Barros; Diana Penha; Klaus Irion; Edson Marchiori
Journal:  Lung       Date:  2018-10-09       Impact factor: 2.584

5.  Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

Authors:  Joline S W Lind; Martijn R Meijerink; Anne-Marie C Dingemans; Cornelis van Kuijk; Michel C Ollers; Dirk de Ruysscher; Pieter E Postmus; Egbert F Smit
Journal:  Eur Radiol       Date:  2010-07-13       Impact factor: 5.315

6.  Vasculature surrounding a nodule: A novel lung cancer biomarker.

Authors:  Xiaohua Wang; Joseph K Leader; Renwei Wang; David Wilson; James Herman; Jian-Min Yuan; Jiantao Pu
Journal:  Lung Cancer       Date:  2017-10-27       Impact factor: 5.705

7.  Feasibility of perfusion CT technique integrated into conventional 18FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study.

Authors:  Davide Ippolito; Cristina Capraro; Luca Guerra; Elena De Ponti; Cristina Messa; Sandro Sironi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-10       Impact factor: 9.236

8.  Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer.

Authors:  P Veit-Haibach; D De Ruysscher; W van Elmpt; M Das; Martin Hüllner; H Sharifi; K Zegers; B Reymen; P Lambin; J E Wildberger; E G C Troost
Journal:  Radiother Oncol       Date:  2013-09-14       Impact factor: 6.280

Review 9.  CT perfusion in oncology: how to do it.

Authors:  G Petralia; L Bonello; S Viotti; L Preda; G d'Andrea; M Bellomi
Journal:  Cancer Imaging       Date:  2010-02-11       Impact factor: 3.909

10.  Enhancement patterns of pancreatic adenocarcinoma on conventional dynamic multi-detector row CT: correlation with angiogenesis and fibrosis.

Authors:  Yuki Hattori; Toshifumi Gabata; Osamu Matsui; Kentaro Mochizuki; Hirohisa Kitagawa; Masato Kayahara; Tetsuo Ohta; Yasuni Nakanuma
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.